American Enterprise Institute | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

14,031 results for “American Enterprise Institute”

Insurance Denials for Brand-Name Drugs Surge 67% Over Six Years, JAMA Study Finds

PBM Reform Bill Shows Strong Promise for 2024 Passage, Aims to Boost Drug Pricing Transparency

Global Pharma Investment in China Surges to $48.5 Billion in First Half of 2025, Doubling 2024 Total

Enterprise Therapeutics Appoints Annabella Amatulli as Head of Regulatory Affairs

Enterprise Generative AI in Pharma: Navigating Cautious Adoption for Transformative Impact

Norway's Health System Renews Nationwide Adoption of Wolters Kluwer UpToDate Enterprise Edition, Adding AI-Powered Clinical Decision Support

US Oncology Enterprise Faces Unprecedented Financial Crisis as NCI Budget Cuts Threaten Cancer Research Infrastructure

Apimeds Pharmaceuticals Raises $13.5M in NYSE American IPO

Enterprise Therapeutics' ETD001 Shows Promise as Novel Inhaled ENaC Blocker for Cystic Fibrosis Treatment

Enterprise Therapeutics' ETD001 Demonstrates Significant Lung Function Improvement in Phase 2 Cystic Fibrosis Trial

Page 1 of 909